Event Content

As environmental and social responsibility gains prominence in EU trade policy, Latin America’s pharmaceutical sector is experiencing significant shifts. This session will offer a market overview of evolving trade patterns, highlighting how new EU requirements—such as Environmental Risk Assessments (ERAs)—...

The rapid advancement of mRNA therapies, gene editing, and personalized medicine is transforming drug development, yet analytical bottlenecks in nanoparticle characterization slow down progress. This session explores how emerging technologies, AI-driven data processing, and innovative analytical methodolog...

In the pharmaceutical industry, packaging is evolving from a simple protective function to a powerful tool for consumer engagement. Smart, connected packaging technologies are transforming how consumers interact with pharma products, offering personalized experiences, real-time health information, and enha...

This session will address one of the pharmaceutical sector's greatest sustainability challenges: tackling Scope 3 emissions, which are the indirect emissions occurring throughout a company's value chain. Since no single company can achieve net-zero targets independently, the panel will explore how cross-in...

Are you ready to take your drug formulations to the next level? Don’t miss this game-changing presentation on how combining Wet Bead Milling with Spray Dried Dispersion—also known as spray drying of API nanosuspensions—can revolutionize your approach to drug delivery and improve the outcomes of your clinic...

Research and Development (R&D) programs rely heavily on the effective sourcing of high-quality materials under aggressive timelines. Maintaining a group of preferred suppliers that have been rigorously vetted to meet these standards is an essential element to assure the effective management of the CMC supp...

The biotech industry is poised for recovery as IPOs and corporate dealmaking gain momentum in 2025, driven by renewed investor confidence and strategic activity within the sector. A combination of increased M&A interest, evolving investor preferences, and alternative capital-raising options highlights the ...

Join Molly Klote, former Director of the Office for Human Research Protections (OHRP), as she closes out CPHI Americas, discussing the shifting dynamics of U.S. pharma. From regulatory pressures to policy uncertainty, this closing address offers a thought-provoking take on where the industry stands—and whe...

Informa collaborates with the industry's leading sustainability associations to forge the Pharmaceutical future and support sustainable practices. Be the first to hear about groundbreaking initiatives and the latest news on these new partnerships, set to revolutionize the industry at the next Pharmapack Ed...

The recent move by the FDA to reclassify VHP sterilization as an Established Category A technology is a significant development for makers of single use medical devices and packaged, prefilled syringes. VHP’s ongoing technology journey and the ever-increasing growth of innovative medical devices are well ...

Discover how Novo Nordisk is driving environmental innovation with its Circular for Zero strategy, which aims for zero environmental impact. This session delves into Novo Nordisk’s proactive approach to tackling plastic waste by focusing on reducing, changing, and avoiding plastic use from product design a...

Understanding Nitrosamines: Exploring the presence, formation, and risks associated with nitrosamines in pharmaceuticals. • Developing proactive strategies to mitigate nitrosamine risks throughout the supply chain. • Implementing safety components and protocols to prevent nitrosamine contamination i...

Even though it should be considered part of our everyday business, is it standard for multimodal CDMOs to truly operate with a holistic quality mindset, prioritizing the health and safety of both workers and patients? At FUJIFILM Diosynth Biotechnologies, quality and safety are two sides of the same coin...

There are two major themes that involve primary packaging components in the revised EU GMP Annex 1 issued in August 2023. This recent revision includes: • Implementing a holistic Contamination Control Strategy (CCS) • Container Closure Integrity (CCI) because a properly seated stopper represents a...

Join us on October 9th at 14.15 to discover how you can revolutionize your operations, and maximize efficiency with Akkodis' AI-powered solutions for the Life Sciences & Healthcare industry. Our presentation, "Optimize Total Cost of Ownership in Life Sciences & Healthcare" will unveil cutting-edge strategi...

Join our opening keynote to review the current state of sustainable practices, environmental impact, and the road towards a greener future for pharma – how do we get there faster?

This session will provide a comprehensive overview of the challenges and opportunities in decarbonizing pharmaceutical supply chains, showcasing the potential of industry-wide programs like Energize and the practical guidance offered by the PSCI Decarbonization Maturity Model. • Assessing the challenge...

We are all willing to have sustainable products for the future. The open question is: how do we get there? This sustainability conference will start with inspiring experiences from sustainable healthcare initiatives. Presentations the focus on potential pathways and drivers for decarbonization of drug ...

The validation of healthcare products and sterile barrier packaging prior to placing on the market is of the upmost importance to the safety of end user and patient. This presentation will give an overview of supporting testing and provide guidance on conducting successful studies.

Product/patient safety is paramount, so how to balance the selection of packaging materials and systems with sustainability in mind? More sustainable solutions are coming online in different forms and need to be scaled into the market. Challenges on the innovation side focus on the validation of imp...

Overcoming challenges when developing subcutaneous drug delivery devices that empower patient self-administration. The trend in parenteral patient therapy has been moving towards the home-care setting for some time as it empowers patient independence. However, home administration brings additional requi...

The pharmaceutical landscape is undergoing a dynamic transformation, driven by technological advancements and a renewed perspective on collaborations. Central to this transformation is the role of CDMOs as strategic partners. In addition to providing access to the cutting-edge technologies th...

>R&D Review – What are the Therapies of the Future?

Cell & Gene Therapies bring a promising future for many serious and rare disease patients. However, manufacturing these treatments represent a lot of challenges and can represent a barrier to the development and thus limiting broader access to these promising cures.
Seqens, with the ongoing acquisit...

Join us as we dive into the key considerations of choosing a CDMO as a biotech, and how to select the perfect partner: • Establishing a pre-partner checklist of what you need (regulation, manufacturing technology, and logistics) to avoid unnecessary costly measures • Why understanding your molecul...

Companies must have the right partner to avoid potential setbacks in clinical development. To avoid disappointment, join our panel and gain expert analysis and best practices in sourcing the right CDMO for your study: • Strategies for getting the most out of our CDMO partnership – mapping objectives, d...

Join our focused session, where our market expert will provide an insightful analysis of the supply chain set-up from the pandemic to now. Understand the industry learnings from Covid and what has evolved within the supply chain industry: • Reviewing current developments in pharmaceutical supply chain ...

In pharma, it is essential to identify the right partner to ensure a successful outcome. Time and time again, mistakes have been made in this process, causing clinical studies to fail and for the company to take a heavy hit. Want to avoid this? join our one-hour masterclass where we will devise a checklist...

Rapid and efficient development of drug candidates is increasingly important for pharmaceutical companies with accelerated timelines and funding constraints. However, many early drug candidates have poor oral absorption properties making it challenging to achieve target pharmacokinetic (PK) profiles. Witho...

In 2022, the final recommendations of the Product Quality Research Institute were published for Parenteral Drug Products. Apart from the wealth of information and considerations on design of extractable & leachable studies for parenteral drug products in general, it also contains valuable information on sp...

New therapeutic treatments or prophylactic vaccines rely on more complicated drug formulations, often based on biologics. These drugs are highly sensitive and might require low temperature storage to keep them stable over shelf life. These extreme cold supply chain processes, something up to -80°C, provide...

Our healthcare industry is evolving. The move from IV to SC injection is being driven by lifecycle management, biosimilar adoption, and the hospital to home trend. Molecules are getting more complex, and patients drive the preference for self-administration resulting in the need for more complex combinatio...

This session will give insights on the trends our sector is facing: decarbonization and circular economy. It will also provide an overview on the work done at industry level. And finally, you will be able to learn more on what Saint-Gobain Life Sciences is willing to offer to supply single-use technologies...

More than 75 % of new chemical entities are poorly soluble and require bioavailability-enhancing excipients. The application of excipients in advanced pharmaceutical processes, such as hot melt extrusion and 3D-printing, aligned with advanced approaches towards personalized medicine, requires special featu...

Novai is commercialising DARC, a combination biomarker consisting of Annexin A5 conjugated to a fluorophore (Dy776). ANX776 binds to stressed/apoptotic retinal cells which are visualisable as white spots using equipment routinely used by opticians, optometrists, and ophthalmologists. The images are then an...

In recent years, the standardization of biologics manufacturing processes has given product developers multiple viable options for producing biologics. These options include building an in-house production system or partnering with a contract biologics manufacturer. Although building in-house does offer th...

Technological innovation in Pharma and Life Science is happening now!

Metaverse, Artificial Intelligence, Data Analytics, Machine Learning, Digitalization: these topics are ranking high on the agenda of the business leaders who understand the competitive advantages that can be seized by moving n...

In this webinar, originally broadcast as a part of Pharmapack Europe 2022, Isabelle Jenny, Sustainability Manager, Amcor in collaboration with Healthcare Plastics Recycling Council (HPRC) discusses as consumers awareness and demand continues to grow, switching to sustainable packaging materials and practic...

The presentation will be about the Gerresheimer – roadmap to decarbonization. The speaker will cover supplier-specific approaches like the furnace technology. Furthermore, Value-chain-comprising approaches in Ph-business (eg eco-design development) will be explained. In the end, success stories about joint...

In this webinar, originally part of Pharmapack Europe 2022, S. Ross Tsakas, Pharmaceutical Segment Leader, Sterigenics discusses parenteral drug development. Parenteral drugs and the drug development lifecycle represent complexities across the multi-year, multi-million pledges made. With over 90 years of e...

In this webinar, originally broadcast as part of the Pharmapack Europe show, speakers Michael Earl, Director Pharmaceutical Services, Sian Eden Business Development Manager, Olivia Houselander Business Development Manage, Denis Marteau General Manager, Pharmaceutical Services, Oli Gould Design Team Manager...

This presentation will provide an overview of the differences and similarities of E&L requirements between pharmaceutical products and medical devices. The key elements regarding E&L testing design of combination products will be discussed. Several case studies on the extractables and leachables testing of...

Join our panel discussion, where out experts will conduct a deep dive through the challenges in drug manufacturing. Key discussion points include: Bottlenecks in skilled workforce and what can be done to overcome this Assessing the challenges in both product and manufacturing quality and identifying...

CDMO’s accelerating adoption Reshoring: CM can help when competing with Asian producers on price. Government investment during Covid to protect against supply chain issues & increased focus on critical drugs supply New guidance based on GMP - ICH Q13 will likely see smaller companies deciding to ...

In this webinar is originally broadcast as part of CPHI North America, with speakers Robert Bloder, Chief Business Officer, Ascendia Pharma, Chris Senanayake, CEO & CSO, TCG GreenChem, Inc. and John Pennett, Partner-in-Charge of the National Technology and Life Sciences Group, EisnerAmper. The thread line:...